{'52WeekChange': -0.62771285,
 'SandP52WeekChange': 0.0644362,
 'address1': '301 Binney Street',
 'address2': 'Suite 402',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.35,
 'askSize': 900,
 'averageDailyVolume10Day': 238550,
 'averageVolume': 324844,
 'averageVolume10days': 238550,
 'beta': 2.025182,
 'beta3Year': None,
 'bid': 2.21,
 'bidSize': 1000,
 'bookValue': 4.378,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cambridge',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.24,
 'dayLow': 2.14,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 0.303,
 'enterpriseToRevenue': -8.293,
 'enterpriseValue': -16469112,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 2.1252856,
 'fiftyTwoWeekHigh': 6.439,
 'fiftyTwoWeekLow': 1.35,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 16975214,
 'forwardEps': -1.68,
 'forwardPE': -1.327381,
 'fromCurrency': None,
 'fullTimeEmployees': 76,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.21441999,
 'heldPercentInstitutions': 0.51702,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1503878400,
 'lastSplitFactor': '1:7',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/synlogictx.com',
 'longBusinessSummary': 'Synlogic, Inc., a clinical-stage biopharmaceutical '
                        'company, focuses on the discovery and development of '
                        'synthetic biotic medicines to treat metabolic, '
                        'inflammatory, and cancer diseases in the United '
                        'States. Its therapeutic programs include SYNB1618, an '
                        'oral therapy that is in Phase I/IIa clinical trial to '
                        'treat phenylketonuria. The company is also developing '
                        'SYNB1891, an intratumorally administered synthetic '
                        'biotic medicine that is in Phase I clinical trial to '
                        'treat solid tumors and lymphoma. It has a '
                        'collaboration agreement with Ginkgo Bioworks for the '
                        'development of synthetic biotic medicines. Synlogic, '
                        'Inc. is headquartered in Cambridge, Massachusetts.',
 'longName': 'Synlogic, Inc.',
 'market': 'us_market',
 'marketCap': 73229856,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_268899196',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -54255000,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.22,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-401-9975',
 'previousClose': 2.19,
 'priceHint': 4,
 'priceToBook': 0.509365,
 'priceToSalesTrailing12Months': 36.87304,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.24,
 'regularMarketDayLow': 2.14,
 'regularMarketOpen': 2.22,
 'regularMarketPreviousClose': 2.19,
 'regularMarketPrice': 2.22,
 'regularMarketVolume': 175366,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 32838500,
 'sharesPercentSharesOut': 0.01,
 'sharesShort': 329360,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 674689,
 'shortName': 'Synlogic, Inc.',
 'shortPercentOfFloat': 0.0195,
 'shortRatio': 0.92,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'SYBX',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.668,
 'twoHundredDayAverage': 2.2196403,
 'volume': 175366,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.synlogictx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02142'}